Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Baricitinib improved hair loss and arthritis in a lupus patient.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Some drugs for inflammation may cause psoriasis-like hair loss.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

PRP injections may be an effective treatment for severe hair loss.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Ruxolitinib can help regrow hair in severe alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.